Results 31 to 40 of about 8,213 (210)
BMC Health Services Research, 2022 Background Ototoxicity monitoring is uncommon in South Africa, despite the increased use of ototoxic medication to manage the burden of disease in the country.
Jessica Paken +3 more
doaj +1 more source
The Ototoxicity of Antimalarial Drugs—A State of the Art Review
Frontiers in Neurology, 2021 This review summarizes current knowledge about the occurrence of hearing and balance disorders after antimalarial drugs treatment. It also examines the clinical applications of antimalarials, their mechanisms behind this ototoxicity and how it can be ...
Magdalena Jozefowicz-Korczynska +2 more
doaj +1 more source
Clinical Issues Surrounding Once-Daily Aminoglycoside Dosing in Children [PDF]
, 2003 Aminoglycoside antibiotics are first-line treatment for many infectious diseases in the pediatric population and are effective in adults. The traditional dosing interval in children is every 8–12 hours.
Buss, William F. +2 more
core +2 more sources
Bucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes. [PDF]
, 2015 Bucillamine is used for the treatment of rheumatoid arthritis. This study investigated the protective effects of bucillamine against cisplatin-induced damage in auditory cells, the organ of Corti from postnatal rats (P2) and adult Balb/C mice.
Choe, Seong-Kyu +11 more
core +2 more sources
Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants. [PDF]
, 2016 To evaluate the impact of gentamicin exposure on sensorineural hearing loss (SNHL) in very low birth weight (VLBW) infants. Exposure to gentamicin was determined in infants born between 1993 and 2010 at a gestational age < 32 weeks and/or with a ...
Bickle Graz, M. +6 more
core +2 more sources
Antibiotic Adverse Reactions and Drug Interactions [PDF]
, 2008 Magnetic force microscopy (MFM) offers a unique insight into the nanoscopic scale domain structures of magnetic materials. However, MFM is generally regarded as a qualitative technique and, therefore, requires meticulous calibration of the magnetic ...
Dr.yekefallah, leili
core +4 more sources
Medical management of Pseudomonas aeruginosa endocarditis: A case report
Journal of Microbiology and Infectious Diseases, 2023 Background: Pseudomonas aeruginosa is a rare cause of infective endocarditis. There is no standard treatment regimen for the management of infective endocarditis caused by this organism. Pseudomonas aeruginosa produces biofilm on the endocardial surface
Sameer Abdul Samad +5 more
doaj +1 more source
South African Family Practice, 2015 Introduction: Aminoglycosides used for treating multidrug-resistant (MDR) tuberculosis are ototoxic, leading to a need for audiological monitoring. While audiologists monitor ototoxicity, currently there are no guidelines on monitoring in the South ...
M. Govender, J. Paken
doaj +1 more source
Distortion-Product Otoacoustic Emission Test Performance for Ototoxicity Monitoring [PDF]
Ear & Hearing, 2011 A nonbehavioral method for monitoring ototoxicity in patients treated with cisplatin is needed because patients enduring chemotherapy may not be well or cooperative enough to undergo repeated hearing tests. Distortion-product otoacoustic emissions (DPOAEs) provide a nonbehavioral measure of auditory function that is sensitive to cisplatin exposure ...
Kelly M, Reavis +7 more
openaire +2 more sources
Vancomycin toxicity in neonates: a review of the evidence. [PDF]
, 2016 PURPOSE OF REVIEW: Vancomycin is a first-line agent in the treatment of serious Gram-positive infections in the neonatal population. The published evidence on vancomycin toxicity in neonates is limited.
Heath, PT +3 more
core +1 more source